title: Peroxisome proliferator-activated receptors in HCV-related infection.
abstract: The topic of peroxisome proliferator-activated receptors has been developed in the field of hepatology allowing envisaging therapeutic strategies for the most frequent chronic liver diseases such as chronic infection with hepatitis C virus (HCV). PPARs contribute to wide physiological processes within the liver such as lipid/glucid metabolisms, inflammatory response, cell differentiation, and cell cycle. In vitro experiments and animal studies showed that PPARα discloses anti-inflammatory property, and PPARγ discloses anti-inflammatory, antifibrogenic, and antiproliferative properties in the liver. Experimental and human studies showed impaired PPARs expression and function during HCV infection. The available nonhepatotoxic agonists of PPARs may constitute a progress in the therapeutic management of patients chronically infected with HCV.
authors.affiliation: Unité INSERM 795, Université Lille 2, Service des Maladies de l'Appareil Digestif et de la Nutrition, Hôpital Huriez, CHRU Lille, 59037 Lille, France. s6@chru-lille.fr
authors.forename: Sébastien
authors.initials: S
authors.lastname: Dharancy
authors.forename: Maud
authors.initials: M
authors.lastname: Lemoine
authors.forename: Philippe
authors.initials: P
authors.lastname: Mathurin
authors.forename: Lawrence
authors.initials: L
authors.lastname: Serfaty
authors.forename: Laurent
authors.initials: L
authors.lastname: Dubuquoy